Tezepelumab (Tezspire) reduced nasal polyps and symptoms in severe chronic rhinosinusitis while also decreasing need for further treatments, the WAYPOINT trial showed. The monoclonal antibody against ...

Medically reviewed by Jurairat J. Molina, MD Chronic rhinosinusitis is inflammation of the sinuses and nasal passages that ...

An international collaboration of researchers, sponsored by GSK and working on behalf of the ANCHOR-1 and ANCHOR-2 trial ...

Usually, your doctor can tell if your sinuses are blocked based on your symptoms and a physical exam ... particularly hay fever Polyps or growths in your nose Nose obstructions, such as a deviated ...

But the flip side is also true: By making a few small changes to your routine, it’s possible to ease the symptoms of nasal polyps, says Tran Bao Locke, MD, an otolaryngologist and assistant ...

The asthma medication reduces congestion in patients with severe, uncontrolled chronic rhinosinusitis with nasal polyps in a ...

Additional symptoms include ear fullness ... on reducing inflammatory burden and trying to restore normal mucociliary function. The presence of nasal polyps is relevant but does not change first-line ...

“Many of them were reporting that their nasal polyp symptoms and related quality of life were greatly improved shortly after taking this drug in the clinic, where we also noticed their polyps ...

Opens in a new tab or window Share on LinkedIn. Opens in a new tab or window SAN DIEGO -- Tezepelumab (Tezspire) reduced nasal polyps and symptoms in severe chronic rhinosinusitis while also ...